Press Release

  • DTIF-funded project, OsStic® technology awarded #BreakthroughDevice designation by the FDA.

    , , , ,

    Shannon, Ireland, February 12th 2024: Irish medical device company Biomimetic Innovations Ltd, an affiliate of PBC Biomed, announced ‘Breakthrough Device’ designation from the Food and Drug Administration FDA in January, for the development of a groundbreaking new bio-adhesive bone void filler technology called OsStic®.  PBC Biomed leads a consortium for this development project, which is…

    Read More...

  • FDA grants global Medical Device company Biomimetic Innovations ‘Breakthrough Device’ designation for OsStic® Synthetic Injectable Structural Bio-Adhesive Bone Void Filler. 

    , , ,

    Shannon, Ireland, 19th January, 2024: Biomimetic Innovations Ltd today announced that OsStic® has been granted ‘Breakthrough Device’ designation by the FDA. The proposed indication statement for this novel new technology is; ” OsStic®Synthetic Injectable Bone Void Filler is a structural, mechanically enhanced bioadhesive for reduction, provisional fixation, or void filling of peri-articular fractures or defects…

    Read More...

  • PBC Biomed announces opening of Memphis office

    PBC BioMed, a medical device design and development company headquartered in Shannon, Ireland, today announced that it will open first U.S. office in Memphis, TN. The PBC BioMed Leadership team, Gerard Insley, Chief Science Officer, Dr. Thomas Russell, Chief Medical Officer, and Brittney Martinez, VP of Business Development and Marketing, were on-site this week for…

    Read More...

  • PBC BioMed announces launch of new innovation management tool ‘AIM’.

    ,

    With an established track record of innovation, PBC BioMed has assembled a global team with a deep understanding of the regulatory, quality, clinical and commercial requirements facing innovators based in the EU or US, and wishing to enter new markets.

    Read More...

  • Collaboration with Curasan AG on Musculoskeletal Regeneration

    ,

    Shannon, Ireland, 8 June, 2021: PBC Biomed, an Irish-based Medical Device Company, have entered a partnership agreement with Curasan AG, a German-headquartered Medical Device company with global distribution, to develop innovative products in the field of musculoskeletal regeneration. This collaboration will bring together two pioneers in the advancement of biomimetic technologies to create an expanded…

    Read More...

  • PBC Biomed to Lead Consortium in Development of Bone Adhesive

    ,

     PBC Biomed_Our Why.mp4 SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) — PBC Biomed, an Irish-based Medical Device Company, will lead a consortium comprised of Biodesign Europe and SFI Research Centre for Advanced Manufacturing (I-Form) at Dublin City University and Dolmen Design & Innovation, a Dublin-based product design company, in developing a bone adhesive for…

    Read More...

  • Biomimetic Innovations, a collaboration between long time friends and colleagues

    ,

    We are delighted to announce the launch of Biomimetic Innovations , a collaboration between long time friends and colleagues, to further develop OsStic™ our biomimetic adhesive for tissue repair. Read More ..’In Vivo Safety Assessment of a Bio-Inspired Bone Adhesive’ J Mater Sci Mater Med 2020, 31(2):24

    Read More...

  • Contract Manufacturer for Copper Hawk

    ,

    PBC Biomed is pleased to announce its role as Contract Manufacturer for Copper Hawk. Copper Hawk is an Irish company dedicated to improving animal health through the development of products made from natural sources. Eire Hide®, one such product, is a formulated, soothing ointment that is applied to animal skin. Please contact us for any…

    Read More...